Evidence map›Paper›PMID 26833042›Full record

ArticleHeart and vessels2016

Repetitive restriction of muscle blood flow enhances mTOR signaling pathways in a rat model.

Toshiaki Nakajima, Tomohiro Yasuda, Seiichiro Koide, Tatsuya Yamasoba, Syotaro Obi, Shigeru Toyoda, Yoshiaki Sato, Teruo Inoue, Yutaka Kano

Abstract read
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Toshiaki NakajimaDepartment of Cardiovascular Medicine, Dokkyo Medical University and Heart Center, Dokkyo Medical University Hospital, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan. nakat@dokkyomed.ac.jp.ORCID http://orcid.org/0000-0001-9545-7529
Tomohiro YasudaSeirei Christopher University, Shizuoka, Japan.
Seiichiro KoideDepartment of Engineering Science, Bioscience and Technology Program, University of Electro-Communications, Tokyo, Japan.
Tatsuya YamasobaDepartment of Otolaryngology, University of Tokyo, Tokyo, Japan.
Syotaro ObiDepartment of Cardiovascular Medicine and Research Support Center, Dokkyo Medical Univerasity, Tochigi, Japan.
Shigeru ToyodaDepartment of Cardiovascular Medicine, Dokkyo Medical University and Heart Center, Dokkyo Medical University Hospital, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.
Yoshiaki SatoDepartment of Basic Sciences in Medicine, Kaatsu International University, Battaramulla, Sri Lanka.
Teruo InoueDepartment of Cardiovascular Medicine, Dokkyo Medical University and Heart Center, Dokkyo Medical University Hospital, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.
Yutaka KanoDepartment of Engineering Science, Bioscience and Technology Program, University of Electro-Communications, Tokyo, Japan.
Dokkyo Medical University · JPUniversity of Electro-Communications · JPSeirei Christopher University · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle is a plastic organ that adapts its mass to various stresses by affecting pathways that regulate protein synthesis and degradation. This study investigated the effects of repetitive restriction of muscle blood flow (RRMBF) on microvascular oxygen pressure (PmvO2), mammalian target of rapamycin (mTOR) signaling pathways, and transcripts associated with proteolysis in rat skeletal muscle. Eleven-week-old male Wistar rats under anesthesia underwent six RRMBF consisting of an external compressive force of 100 mmHg for 5 min applied to the proximal portion of the right thigh, each followed by 3 min rest. During RRMBF, PmvO2 was measured by phosphorescence quenching techniques. The total RNA and protein of the tibialis anterior muscle were obtained from control rats, and rats treated with RRMBF 0-6 h after the stimuli. The protein expression and phosphorylation of various signaling proteins were determined by western blotting. The mRNA expression level was measured by real-time RT-PCR analysis. The total muscle weight increased in rats 0 h after RRMBF, but not in rats 1-6 h. During RRMBF, PmvO2 significantly decreased (36.1 ± 5.7 to 5.9 ± 1.7 torr), and recovered at rest period. RRMBF significantly increased phosphorylation of p70 S6-kinase (p70S6k), a downstream target of mTOR, and ribosomal protein S6 1 h after the stimuli. The protein level of REDD1 and phosphorylation of AMPK and MAPKs did not change. The mRNA expression levels of FOXO3a, MuRF-1, and myostatin were not significantly altered. These results suggested that RRMBF significantly decreased PmvO2, and enhanced mTOR signaling pathways in skeletal muscle using a rat model, which may play a role in diminishing muscle atrophy under various conditions in human studies.

Indexed as

Signal TransductionAnimalsHypoxiaMaleMuscle, SkeletalMuscular AtrophyPhosphorylationRatsRats, WistarRibosomal Protein S6Ribosomal Protein S6 Kinases, 70-kDaRNA, MessengerTOR Serine-Threonine KinasesmTOR protein, ratRibosomal Protein S6Ribosomal Protein S6 Kinases, 70-kDaRNA, MessengerTOR Serine-Threonine KinasesBlood flow restrictionHypoxiaMammalian target of rapamycin (mTOR)Microvascular pO2Muscle atrophyMyostatinp70 S6-kinaseRat skeletal muscle

Identifiers

PMID26833042
OpenAlexW2270516616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.